Petros Pharmaceuticals, Inc. (PTPI) Total liabilities 2020–2024
Petros Pharmaceuticals, Inc. (PTPI) total liabilities at each fiscal year-end, per SEC filings.
$18.1MFY2024 · since FY2020: $52.4M → $18.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $18.1M | -15.1% |
| FY2023 | $21.3M | +35.6% |
| FY2022 | $15.7M | -50.6% |
| FY2021 | $31.8M | -39.2% |
| FY2020 | $52.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PTPI financial trends
PTPI RevenuePTPI Net incomePTPI Net marginPTPI Gross profitPTPI Gross marginPTPI Operating incomePTPI Operating marginPTPI Operating cash flowPTPI Free cash flowPTPI Capital expendituresPTPI Return on equityPTPI Stock buybacksPTPI Dividends paidPTPI Total assetsPTPI Shareholders’ equityPTPI overview →